Q: In response to other questions CRH has restated its last quarter financial announcement
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Hi, Any comments on the unabated selling and advice on future course of action ? Guess, we can always hold for year end capital loss, but is it worth waiting or you see any light at the end of the tunnel? Thanks for your valued insight.
Q: What's going on with crh?
Would you be comfortable to buy at these levels?
Keep up the good work."...
Would you be comfortable to buy at these levels?
Keep up the good work."...
Q: Today, Cardiome jumped 8% in a down market based on receiving approval from Health Canada to market Brinavess and seem to have had a solid Q1 with Aggrastat. New product commercialization and launches are scheduled for next month and seem to have momentum. Can I have your assessment? Thank you for your support.
Marty
Marty
Q: Would appreciate your views on PLI in light of recent announced financials.
Thanks
John
Thanks
John
Q: I am down more than 30% on CRH on a small position. Is it still wort keeping or time to move on to better stocks..
Q: Would IBB be best in a TFSA or non-registered
Q: Hi Folks
Is there a Canadian dollar way to play the Biotech industry. Would it be correct to say that IBB would be a US dollar purchase?
Thanks for all you do
GUY R
Is there a Canadian dollar way to play the Biotech industry. Would it be correct to say that IBB would be a US dollar purchase?
Thanks for all you do
GUY R
Q: Your April 27, 2017 response says GUD's patience does not mean anything is wrong. Goodman is currently away in Israel for discussion with Medison
Biotech. Hope GUD goes commercial in 2017. Any comment on this move ?
Biotech. Hope GUD goes commercial in 2017. Any comment on this move ?
Q: Hi All at 5i!!! I know that you don't follow Us stocks BUT...if you had to choose one of the following for a long term hold, which would it be ? Cheers, Tamara...PS. I really hope you will create a Us stock portfolio....just saying....😁😁😁
Q: GUD. Should my entry point of 10.15 be breached, should I remain in, and hope for the best ?
Q: Can you please comment on Savaria's earnings? Thank you
Q: It appears the $1.65/share takeover by Norgine is set for Sept 30, 2017. Between now an then do you see any other upside above $1.65? I read at Pharmpro.com, 'The Arrangement Agreement includes a non-solicitation covenant on the part of Merus, subject to customary "fiduciary out" provisions that entitle Merus to consider and accept unsolicited superior proposals and a right in favour of Norgine to match any superior proposal....'
Q: Hi 5i - can I get your comments on CXR's results? Anything to like here? Thanks, Neil
Q: Although this is probably too early for an opinion about the suggested suit again Span-America, what are you experiences in other similar situations?
Thanks.
Thanks.
Q: Do you know approximately what percentage of Savaria's top line revenue comes from its servicing of the equipment that it has sold?
Q: What do you think is the potential impact of the following? Thanks.
SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Span-America Medical Systems, Inc. And Encourages Investors To Contact The Firm For Additional Information
Details: http://www.businesswire.com/news/home/20170510006321/en/SHAREHOLDER-ALERT-Brower-Piven-Commences-Investigation-Proposed
SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Span-America Medical Systems, Inc. And Encourages Investors To Contact The Firm For Additional Information
Details: http://www.businesswire.com/news/home/20170510006321/en/SHAREHOLDER-ALERT-Brower-Piven-Commences-Investigation-Proposed
Q: Dropping presently due to new purchase. Is this a buying opportunity of concern?
Q: What's your updated view on this name?
Q: Thoughts on recent earnings? Is this a lost cause?